Mr. Speaker, I am thankful for the opportunity to debate this important legislation, Bill C-37. It is a response to the national opioid crisis that is particularly severe in western Canada but is spreading throughout the rest of the country. To be blunt, given the time constraints, this bill will save lives, and I hope every member of the House supports it.
Over the course of time that I have to address this issue, I want to give a very brief background on the scope of the fentanyl crisis facing our country and then tackle some of the things we can do, such as trying to undercut the illicit market for this devastating drug and ensuring we are treating addiction like a life-threatening chronic illness and not a crime.
The scope of this crisis is extraordinarily widespread. We have heard hon. members from different parties address its widespread nature, but I specifically would like to draw the attention of members the fact that 947 lives were lost in British Columbia in 2016. By comparison, death from motor vehicle accidents in somewhere in the range of a little more than 300. In Ontario, I believe, on average, two people die a day from an overdose of opioids. In my home province of Nova Scotia, we are losing one life approximately every five or six days.
This drug is migrating from the west coast to the east coast. Even though we know it is being manufactured and imported from parts of Asia and that British Columbia has borne the brunt of it so far, we need to act now so we can stem the bleeding that is happening on the west coast and prevent disaster to such extremes from affecting the rest of the country as well.
I find that a few measures in Bill C-37 are very helpful and will help undermine the illicit market for fentanyl. One of the first things we can do is tackle the equipment that is being imported to help manufacture this drug locally, things like pill presses and encapsulators. Bill C-37 would ensure that we would not allow the importation of these devices, thereby helping to prevent the production of the drug locally in the first place.
We are also planning on criminalizing the possession of any kind of equipment that can be used with the knowledge that it can be used toward trafficking in controlled substances, such as the law that currently applies to methamphetamines. This is a common-sense approach that will make it harder to produce and distribute this dangerous drug.
Should this legislation pass, we plan on making changes that will allow border services agents greater latitude to inspect suspicious packages, even though they may be smaller than the current norm allows. Again, the reason for this policy change is simple common sense. The potency of this drug is so much stronger than even heroin or other drugs found on the streets today. This needs to be addressed by ensuring that even the smallest amount can be detected and prevented from coming into Canada in the first place.
In addition, Bill C-37 makes serious efforts to divert access of this controlled substance to the underground market by introducing a new scheme that is characterized by monetary penalties to ensure we have a better ability to enforce the laws on the books now. Ensuring that compliance is encouraged, non-compliance is deterred, and that we have an effective mechanism to enforce our rules is a key step in stemming the distribution and production of this drug in Canada.
I would like to spend the remaining time I have on the importance of ensuring addiction is treated like a chronic life-threatening illness rather than a crime. This comes to the key feature of Bill C-37, which is the promotion of safe injection sites. Addicts would have a place where they could get the treatment they needed, rather than turn to the streets and bury themselves in communities where they would not have supports and the outcome of their use of the drug would be far more severe.
In preparing for today's speech, I consulted with medical professionals who had recently done research on this. They explained to me that the research was clear. The traditional approach of detox and abstaining is not one that works, particularly when people successfully try to get off the drug and have episodes of relapse. Their risk of overdose is so much higher because their tolerance is reduced.
If we look at the benefits of harm reduction, there is a handful that, again, appeal to common sense and are borne out on the evidence.
We know that the use of methadone prevents cravings and gives a different kind of high to help reduce addiction. We know that treatment in safe injection sites improves retention for people who do enter treatment. We know that it reduces needle sharing, which reduces the impact. Most important, it reduces death resulting from overdoses of opioids.